纽约医生Daniel Griffin至今年元旦，他治疗了一千多例病人。

本期要点：

In COVID-19 clinical update #47, Daniel Griffin reviews phase 3 results for Novavax and J&J vaccines, transmission in K-12 settings in Wisconsin, data on Lilly and Regeneron monoclonal antibody therapy, and a study of colchicine for treatment of disease.

Links for this episode

• Novavax vaccine phase 3 results (Novavax)
• J&J vaccine phase 3 results (J&J)
• COVID-19 and transmission in K-12 schools (MMWR)
• Lilly mAb therapy (NEJM)
• Regeneron mAb prophylaxis (Regeneron)
• Colchicine for COVID-19 (Cardiol Today)